Autopsy report · NCT05551351

CT in Calcified Coronary Arteries With Photon Counting Detector

“Enrollment rate too slow to reach anticipated number of participants.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 10 months before it stopped.
• 29 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Region Örebro County

Sponsor type

University, hospital or other

Conditions

Coronary Stenosis; Calcific Coronary Arteriosclerosis

Interventions

Cardiac CT with photon counting detector

Participants

29

Sites

1

Countries

Sweden

Trials that died the same way

• Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction
  “Enrollment rate was slower than anticipated.” (80% match in meaning)
• A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
  “Slow participant enrollment” (79% match in meaning)
• Comparison Study of Two Splints Used for Treatment of Acute Temporomandibular Pain.
  “Very slow enrollment of participants” (79% match in meaning)
• Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route
  “Slow rate of enrollment” (78% match in meaning)
• Frequency Specific Microcurrent for the Treatment of Diastasis Recti
  “Enrollment too slow.” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.